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Abstract 
Review on t(11;14)(p15;q22) AP2A2/NID2, with 
data on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
Myelodysplastic syndrome 
Epidemiology 
A single case of Philadelphia chromosome-positive 
chronic myeloid leukemia with t(11;14)(p15;q22) 
following allogeneic stem cell transplantation in a 
32 year-old male is reported in the literature.  
The translocation is associated with a complex 
karyotype. No molecular characterization was 
performed (Karrman et al., 2007). 
Clinics 
A 71-year-old woman seen because of macrocytic 
anemia without etiology. 
Cytology 
Bone marrow aspirate showing dysgranulopoiesis 
and dyserythropoiesis.  
Presence of ring sideroblasts (24%) signing a 
refractory anemia with ring sideroblasts (RARS). 
Evolution 
Patient alive two years later. 
Cytogenetics 
The t(11;14)(p15;q22) involves two genes, the 
AP2A2 and NID2 genes, that have never been 
shown to form a fusion gene. 
 
RHG banding showing chromosomes 11 and 14 and the 
derivatives der(11) and der(14). 
Cytogenetics morphological 
t(11;14)(p15;q22) is identified by banding 
cytogenetics. 
Cytogenetics molecular 
To determine the position of the breakpoints on 
chromosomes 11 and 14, BACs located in the 
bands of interest were used as probes in FISH 
experiments.  
Analysis with RP11-51L17 showed that one signal 
hybridized to the normal chromosome 11, and the 
other hybridized to the der(14).  
Analysis with RP11-963I11 showed that one signal 
hybridized to the normal chromosome 14, and the 
other split and hybridized to both der(11) and 
der(14). Co-hybridization with both BAC clones 
showed one fusion signal.  
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FISH with BACs RP11-51L17 (spectrum orange, located in 11p15 and containing AP2A2) and RP11-963I11 (spectrum green, 
located in 14q22 and containing NID2) showing co-hybridization. During the FISH analyses with BAC clones on chromosome 11, 
we found that RP11-51L17 was translocated to der(14) and RP11-613G2 was deleted. RP11-51L17 is mapped between 
positions 774448 and 952590 and RP11-613G2 between positions 952562 and 1128625. The AP2A2 is mapped from positions 
925809 to 1012245. The region of overlap between both BAC clones is included between exons 1 and 2 of AP2A2 (UCSC 
Genome Browser on Human Feb. 2009 (GRCh37/hg19) Assembly). Deletion of RP11-613G2 explains why only one fusion 
signal was observed. 
 
RP11-51L17 contains the AP2A2 (adaptor-related 
protein complex 2, alpha 2 subunit) gene and RP11-
963I11 the NID2 (Nidogen 2) gene. 
Genes involved and 
proteins 
AP2A2 
Location 
11p15.5 
 
 
DNA/RNA 
The AP2A2 gene contains 22 coding exons, 
spanning 86.4 kb. Three alternative transcripts are 
known (Nagase et al., 1998). 
Protein 
The protein has 939 amino acids. It is a component 
of the adaptor protein complex 2 (AP-2) (Ohno, 
2006). AP-2 is involved in clathrin-dependent 
endocytosis in which proteins are incorporated into 
vesicles surrounded by clathrin (clathrin-coated  
 
t(11;14)(p15;q22) AP2A2/NID2 Douet-Guilbert N, et al. 
 
 
 
 
 
Atlas Genet Cytogenet Oncol Haematol. 2015; 19(3) 229 
vesicles) which are destined for fusion with the 
early endosome. AP-2 is involved in a wide range 
of biological processes, notably signalling mediated 
by Notch, Wnt, EGF and transforming growth 
factor-b (TGF-b) superfamily members (Foerster et 
al., 2013; Mizutani et al., 2010; Sorkin and von 
Zastrow, 2009; Yao et al., 2002; Yu et al., 2007). 
AP2 was also found to be essential for 
thrombopoietin (Tpo)-stimulated clathrin-mediated 
internalization of its receptor c-Mpl. As Tpo 
promotes proliferation and survival of 
hematopoietic stem and progenitor cells and 
regulates megakaryocyte lineage differentiation and 
maturation, Tpo signal transduction has to be 
controlled (Hitchcock et al., 2008). More recently, a 
role for AP2A2 has been suggested in asymmetric 
cell division and self-renewal of hematopoietic 
stem and progenitor cells (Ting et al., 2012). 
NID2 
Location 
14q22.1 
Note 
NID2 expression was shown to be downregulated 
in tumor tissues from patients with hepatocellular 
carcinoma (Cheng et al., 2012). Aberrant 
methylation of NID2 promoter induces loss of gene 
expression in gastrointestinal tumors (stomach and 
colon) and in oral squamous cell carcinoma 
(Guerrero-Preston et al., 2011; Ulazzi et al., 2007). 
DNA/RNA 
The NID2 gene contains 21 coding exons, spanning 
64.4 kb (Kohfeldt et al., 1998). 
Protein 
The NID2 gene encodes a 1375 amino acids protein 
that is a member of the nidogen family of basement 
membranes that control diverse cellular activities, 
including adhesion, migration, differentiation, gene 
expression and apoptosis. Its three dimensional 
structure consists of three globular domains 
connected by a flexible link and a rod (Kohfeldt et 
al., 1998). Disruption of the integrity of the 
basement membrane creates an invasion-permissive 
environment, often promoting cancer cell 
proliferation and invasion (metastasis) (Lester and 
McCarthy, 1992). 
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